Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruch Brenner

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trialBaruch Brenner, Ofer Purim, Noa Gordon, et al.
Radiation Oncology (London, England)|August 3, 2012
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical studyNatalia Goldberg, Yulia Kundel, Ofer Purim, et al.
Frontiers in Oncology|March 17, 2023
The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancerYulia Kundel, Noga Kurman, Omri Sulimani, et al.
Cancers|February 11, 2023
A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring ToolsMeytal Dror Levinsky, Baruch Brenner, Michal Yalon, et al.
The Oncologist|June 9, 2017
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness AnalysisDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
Anticancer Research|November 14, 2013
Ethnic variation in toxicity and outcome of adjuvant chemoradiation for gastric cancer in IsraelRonen M Brenner, Shaye Kivity, Yulia Kundel, et al.
Harefuah|August 7, 2014
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin]Yaniv Berger, Andrew Paul Zbar, Alexander Lebedyev, et al.
Plos One|July 9, 2016
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric CancerBaruch Brenner, Michal Sarfaty, Ofer Purim, et al.
Chemotherapy|December 17, 2008
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancerEfraim Idelevich, Franklin Greif, Eli Mavor, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trialBaruch Brenner, Ofer Purim, Noa Gordon, et al.
Radiation Oncology (London, England)|August 3, 2012
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical studyNatalia Goldberg, Yulia Kundel, Ofer Purim, et al.
Frontiers in Oncology|March 17, 2023
The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancerYulia Kundel, Noga Kurman, Omri Sulimani, et al.
Cancers|February 11, 2023
A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring ToolsMeytal Dror Levinsky, Baruch Brenner, Michal Yalon, et al.
The Oncologist|June 9, 2017
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness AnalysisDaniel A Goldstein, Qiushi Chen, Turgay Ayer, et al.
Anticancer Research|November 14, 2013
Ethnic variation in toxicity and outcome of adjuvant chemoradiation for gastric cancer in IsraelRonen M Brenner, Shaye Kivity, Yulia Kundel, et al.
Harefuah|August 7, 2014
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin]Yaniv Berger, Andrew Paul Zbar, Alexander Lebedyev, et al.
Plos One|July 9, 2016
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric CancerBaruch Brenner, Michal Sarfaty, Ofer Purim, et al.
Chemotherapy|December 17, 2008
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancerEfraim Idelevich, Franklin Greif, Eli Mavor, et al.
International Journal of Oncology|March 20, 2012
Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancerAlina Weissmann-Brenner, Michal Kushnir, Gila Lithwick Yanai, et al.
Pageof 12